Synthetic lethality of decitabine plus ATR inhibition for TP53-mutated AML. [PDF]
Baeten JT +13 more
europepmc +1 more source
S. Zienolddiny, V. Skaug, A. Haugen
openaire +1 more source
Impact of SAMHD1 and phosphorylated ATM levels on the progression and prognosis of patients with soft tissue sarcoma. [PDF]
Kim YJ +7 more
europepmc +1 more source
Targeting the FNIP2-SERCA2b axis improves metabolic and mitochondrial defects in Ataxia Telangiectasia. [PDF]
Vinciguerra M +12 more
europepmc +1 more source
Roles of DNA Damage Response Pathway in the Regulation of the Nuclear Envelope. [PDF]
Kamikawa Y +4 more
europepmc +1 more source
Elimusertib enhances cytotoxic effects of conventional chemotherapy and sensitizes to radiation in preclinical Ewing sarcoma models. [PDF]
Koch L +14 more
europepmc +1 more source
The novel brain penetrant ataxia-telangiectasia mutated inhibitor WSD0628 provides robust radiosensitization of brain tumor patient-derived xenografts. [PDF]
Xue Z +21 more
europepmc +1 more source
Indium (III) chloride inhibits testicular Leydig cell proliferation by disrupting centrosome copy numbers. [PDF]
Wang CY +5 more
europepmc +1 more source
DHX9 phosphorylation at S321 by ATM regulates DHX9 retention at DNA double-strand break sites and interaction with BRCA1. [PDF]
Matsuya S +4 more
europepmc +1 more source
Novel genetic variants identification and immune profiling in ataxia telangiectasia patients. [PDF]
Jenni R +7 more
europepmc +1 more source

